glp-1 drugs for insulin resistance Taking Mounjaro 新闻 -The obesity fighter -

Limited head-to-head studies compare established glucagon-like peptide-1 receptor agonists (GLP-1 RAs), dipeptidyl peptidase-4 inhibitors (DPP-4is), and sodium-glucose co-transporter-2 inhibitors (SGLT-2is) to insulin in the management of uncontrolled type 2 diabetes mellitus (T2DM)

A recent article by Paggers et al

After a median follow-up of 2.5 years, GLP-1 RAs users had lower risks of mortality (adjusted hazard ratio (aHR), 0.39

Does your stomach shrink on GLP-1 medications like Ozempic or Wegovy

A new case report highlights the potential risk of "anhedonia" from high doses of tirzepatide, though it can be treated effectively.

Prime Labs Retatrutide is a high-purity, lyophilized research peptide synthesized for advanced in-vitro applications